STACEY CARABIN: Open Payments
NPI 1699200162 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 23 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $311 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $204 |
| Neurocrine BioSciences, Inc. | 2 | $147 |
| ABBVIE INC. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Bausch Health US, LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: Auvelity, INGREZZA, VRAYLAR, SPRAVATO, CAPLYTA, COBENFY, ABILIFY MAINTENA, APLENZIN.
Industry payments across OH — which companies pay providers there.
